Valneva SE (VALN) Cash & Current Investments (2020 - 2026)

Valneva SE's (VALN) quarterly Cash & Current Investments came in at $123.2 million in Q1 2026, down 30.37% year-on-year from $177.0 million in Q1 2025, and down 3.45% quarter-over-quarter from $127.6 million in Q4 2025.

Valneva SE (VALN) Cash & Current Investments (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Cash & Current Investments across 7 years of filings, most recently posting $123.2 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $123.2 million, down 30.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $123.2 million (down 30.37% YoY), and the FY2025 annual result was $127.6 million, down 29.55% from the prior year.
  • Cash & Current Investments came in at $123.2 million for Q1 2026 at Valneva SE, down from $127.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $389.0 million in Q1 2022 to a low of $312011.7 in Q2 2023.
  • The 5-year median for Cash & Current Investments is $181.2 million (2024), against an average of $207.3 million.
  • Across the five-year window, Cash & Current Investments plunged 99.91% in 2023 and jumped 45256.32% in 2024, its largest moves.
  • Valneva SE's Cash & Current Investments stood at $292.3 million in 2022, then sank by 53.6% to $135.7 million in 2023, then jumped by 33.56% to $181.2 million in 2024, then declined by 29.55% to $127.6 million in 2025, then decreased by 3.45% to $123.2 million in 2026.
  • The last three Cash & Current Investments figures came in at $123.2 million (Q1 2026), $127.6 million (Q4 2025), and $167.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 32.30 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 2.13 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 2.77 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 18.44 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 7.25 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 123.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 123.24 Mn
Dec 31, 2025 127.64 Mn
Sep 30, 2025 167.76 Mn
Jun 30, 2025 184.08 Mn
Mar 31, 2025 177.00 Mn
Dec 31, 2024 181.19 Mn
Sep 30, 2024 171.65 Mn
Jun 30, 2024 141.52 Mn
Mar 31, 2024 191.89 Mn
Dec 31, 2023 135.65 Mn
Sep 30, 2023 311.92 Mn
Jun 30, 2023 312,011.68
Mar 31, 2023 307.55 Mn
Dec 31, 2022 292.33 Mn
Sep 30, 2022 263.20 Mn
Jun 30, 2022 358.77 Mn
Mar 31, 2022 389.05 Mn
Dec 31, 2021 396.60 Mn
Sep 30, 2021 241.04 Mn
Jun 30, 2021 397.13 Mn